Longterm regulatory relations
Since 1982, Welbeck Medicals relationships with regulatory bodies and pharmaceutical organisations have grown from strength to strength. This partnership has certainly been an influential factor in the way the business has thrived.
Welbeck Medical works with regulatory bodies (like the MHRA) and this means it is always up-to-date with current regulations and directives. Welbeck bases its business on a healthy and harmonised relationship with these regulatory agencies. We work in tandem, ensuring that the process of supplying 'named patient' products is of the top quality, and that all the complex and intricate processes involved in supplying are efficiently handled. It also means that our international suppliers are also regulated.
GDP, GPVP and SOP
Welbeck Medical follows the 'Good Distribution Practice' (GDP) and also maintains 'Good Pharmacovigilance Practice' (GPvP) as set out by regulatory agency guidelines.
Our Standard Operating Procedure (SOP) is continually revised and we try to be pro-active in order to be ahead of any future changes that may occur in supply policy.